en

PRODUCT DETAIL

Tecartus

Code 6267D
MA number EU/1/20/1492/001
Product Form: dis inf 1x68 ml (vak EVA)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XL ?
L01XL06 Brexucabtagene autoleucel
Shelf life: 12
Container: bag ethylene vinyl acetate (EVA)
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 14.12.2020
Validity: 15.12.2024
SmPC + PL: European Medicines Agency's database
Dokument: Karta pacienta SK.pdf  
Dokument: Pokyny pre zaobchádzanie s liekom SK.pdf  
Dokument: Príručka pre zdravotníckych pracovníkov SK.pdf  
Safety feature No
Data update: 18.12.2023
eu-flag.png sk-flag.png